SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTP ICAP Regulatory News (TCAP)

Share Price Information for TP ICAP (TCAP)

Share Price is delayed by 15 minutes
Get Live Data
344.20    8.00 (2.38%)
Bid:
344.00
Ask:
344.40
Spread: 0.40 (0.116%)
Market Cap: £2.51b
TCAP Live PriceLast checked at - London Stock Exchange

Intraday TP ICAP Share Chart

Trading Statement

15 May 2024 07:00

RNS Number : 4453O
TP ICAP Group plc
15 May 2024
 

TP ICAP GROUP PLC ("TP ICAP" or the "Group")

 

15 May 2024

 

Trading update for the three months ended 31 March 2024

 

 

Group revenue performance (in constant currency, unless in brackets, which denotes reported currency)

 

Total Group revenue in Q1 2024 of £570m was 3% down (-6%), after a strong performance in Q1 2023. Performance in April 2024 was very strong. As a result, total revenue for the first 4 months was up 3% (0%). The Board remains comfortable with current market expectations for FY 2024, subject to movements, as previously noted, in foreign exchange rates.

 

Q1 2024 divisional revenue performance

 

In Global Broking, following near record revenue in March 2023, due to the collapse of various US banks, Q1 2024 revenue declined by 7% (-10%). There was a significant rebound in April 2024 when the business recorded strong double-digit growth. Energy & Commodities ('E&C') revenue in Q1 2024 was up 8% (+5%) with the division again benefitting from buoyant market conditions. E&C revenue has increased by 20% (+17%) over the 12 months to March 2024, underlining its position as the world's leading energy broker.

 

Parameta Solutions, the leading provider of OTC data, grew its revenue by 12% (+4%), driven by ongoing demand, new clients, and a focus on direct distribution. At Liquidnet, the Cash Equities business, the largest part of the division, grew by 7% (+2%), building on the momentum established in the latter part of 2023. Following record revenues (+38% in constant currency) in March 2023, generated by the same market conditions as Global Broking, there was a decline in revenue recorded by Agency Execution. As a result, total Liquidnet revenue was down 4% (-8%).

 

Strategic update

 

· Parameta Solutions:

o As previously announced, Silvina Aldeco-Martinez was appointed CEO of Parameta Solutions on 27 March, and Eric Sinclair assumed the role of Chair;

Silvina joined the Group from PitchBook Data, a division of Morningstar, where she was a member of the executive team and CEO of Leveraged Commentary and Data. Prior to that, in her 25 years at S&P Global, Silvina held several senior roles;

Eric was appointed CEO of Parameta Solutions in 2017. His deep market expertise, strong relationships and track record of growing the business complement Silvina's significant experience in the data & analytics sector, as the division continues to leverage its position as the leading OTC data provider;

We continue to explore options to unlock the value of Parameta Solutions for shareholders, including a potential IPO of a minority stake in the business.

· E&C - Energy Transition:

o Tullett Prebon battery metals desk was launched in London and Singapore last month. The desk provides clients with the opportunity to trade across these fast-growing asset classes, which are expected to play a crucial role in the Energy Transition;

Building on its position as the leading Antipodean energy broker, E&C acquired Aotearoa Energy, a New Zealand-based Gas, Power, and Carbon broker, complementing ICAP's market-leading Australian Power & Gas brokerage business and giving clients access to the sought-after New Zealand Emissions market.

 

 

2024 Annual General Meeting

 

The Group will host its Annual General Meeting today, Wednesday 15 May 2024, at 2.15pm (BST) at the offices of Allen & Overy LLP, One Bishop's Square, London, E1 6AD.

 

2024 half year results

 

The Group will report its results for the six months ended 30 June 2024 on 7 August 2024.

 

 

Forward-looking statements

This document contains forward-looking statements with respect to the financial condition, results and business of the Group. By their nature, forward-looking statements involve risk and uncertainty and there may be subsequent variations to estimates. The Group's actual future results may differ materially from the results expressed or implied in these forward-looking statements.

 

Enquiries

Group Company Secretary Vicky Hart

Email: companysecretarial@tpicap.com

Analysts and investors Dominic Lagan Direct: +44 (0) 20 3933 0447

Email: dominic.lagan@tpicap.com

Media Richard Newman Direct: +44 (0) 7469 039 307

Email: richard.newman@tpicap.com

 

About TP ICAP

· TP ICAP connects buyers and sellers in global financial, energy and commodities markets.

· It is the world's leading wholesale market intermediary, with a portfolio of businesses that provide broking services, data & analytics and market intelligence, trusted by clients around the world.

· We operate from more than 60 offices across 28 countries, supporting brokers with award-winning and market-leading technology.

 

Further information on the company and its activities is available on the Group's website: www.tpicap.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFFFVIEIISLIS
Date   Source Headline
23rd Apr 20204:30 pmRNSHolding(s) in Company
17th Apr 202012:09 pmRNSAnnual Financial Report
1st Apr 20207:00 amRNSDirector/PDMR Shareholding - Replacement
24th Mar 20207:00 amRNSDirectorate Change
20th Mar 20207:00 amRNSHolding(s) in Company
17th Mar 202010:52 amRNSHolding(s) in Company
10th Mar 20207:00 amRNSFinal Results
6th Mar 20207:00 amRNSDirectorate Change
18th Feb 20202:54 pmRNSHolding(s) in Company
18th Feb 20207:00 amRNSDirectorate Change
23rd Jan 20205:33 pmRNSHolding(s) in Company
16th Jan 20202:34 pmRNSHolding(s) in Company
24th Dec 20197:00 amRNSProposed acquisition of Louis Capital
23rd Dec 20197:00 amRNSIntroduction of a new Jersey incorporated HoldCo
11th Dec 20199:29 amRNSHolding(s) in Company
1st Nov 20191:58 pmRNSHolding(s) in Company
1st Nov 20197:00 amRNSTrading Statement
31st Oct 20197:00 amRNSTotal Voting Rights
18th Oct 20197:10 amRNSDirectorate Change
11th Oct 20197:00 amRNSSettlement of FCA Investigation
7th Oct 20198:50 amRNSHolding(s) in Company
27th Sep 20197:00 amRNSDirector Declaration and Board Change
19th Sep 20192:22 pmRNSHolding(s) in Company
16th Sep 20194:13 pmRNSAcquisition
14th Aug 20194:41 pmRNSDirector/PDMR Shareholding
6th Aug 20197:00 amRNSFinancial and Interim Management Report
28th Jun 20193:26 pmRNSDirector/PDMR Shareholding
6th Jun 20194:08 pmRNSDirector/PDMR Shareholding
28th May 20191:20 pmRNSPublication of Final Terms
24th May 201910:38 amRNSResult of Tender Offer
16th May 201910:58 amRNSTender Offer
15th May 20195:45 pmRNSPublication of a Prospectus
15th May 20194:41 pmRNSConfirmation of Richard Berliand as Chairman
15th May 20194:37 pmRNSResult of AGM
15th May 20197:00 amRNSAGM Statement and Trading Update
12th Apr 20191:17 pmRNSDirector/PDMR Shareholding
3rd Apr 20195:35 pmRNSDirector/PDMR Shareholding
19th Mar 20197:01 amRNSConfirmation of Director Appointment
19th Mar 20197:00 amRNSFinal Results
1st Mar 20192:58 pmRNSHolding(s) in Company
28th Feb 20192:22 pmRNSHolding(s) in Company
21st Feb 20194:14 pmRNSHolding(s) in Company
7th Feb 20194:15 pmRNSHolding(s) in Company
29th Jan 20192:13 pmRNSStatement re Press Release
28th Jan 20195:00 pmRNSHolding(s) in Company
25th Jan 20197:00 amRNSBoard Committee Changes
17th Jan 20199:17 amRNSHolding(s) in Company
14th Dec 20181:52 pmRNSHolding(s) in Company
14th Dec 20187:00 amRNSDirectorate Change
13th Dec 20189:22 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.